Are you attending the 37th annual @sitcancer conference in Boston?
Make sure to stop by our poster presentation tomorrow, November 11th, 2022!
#SITC22#genetherapy#celltherapy
Congratulations to our friend and collaborator, Dr. Philippa Kennedy, who was awarded the Nicole Gularte Fight for Cures Embassador Award to fund her research. We look forward to continuing to support her research in all her future endeavors! https://t.co/Llvy8Us3Ui
We are pleased to announce our new collaboration with aCGT Vector which aims to further unlock the tremendous promise of #celltherapies and help solve some of the challenges in treating patients with solid tumors. To learn more, please visit: https://t.co/gm3PVdDSJk
It’s a joy and an honor to work with amazing researchers like yourself who everyday are making such an incredible impact in #celltherapy! Thank you for your continued partnership and congrats on winning a well-deserved award from @EWhiteheadFdn for your groundbreaking work!
It's here! Our team is at #CARTCR and ready for a great week. Make sure you stop by our booth (E88) to see our AVATAR AI system first-hand.
Also, don't miss out on James Lim's Tech Slam! Details below. We hope to see you there. #genetherapy#celltherapy#immunotherapy
Excited to share that Xcellbio is sponsoring the third annual Believe Ball in support of the @EWhiteheadFdn. We’re honored to be a part of such an amazing cause. See you there! #EWFBelieveBall
Our 2022 #EWFBelieveBall is almost here! ✨ We cannot wait to #WriteABetterStory for kids fighting cancer with all of you on Saturday, September 17 at the @VFCasinoResort in King of Prussia, PA.
Tickets still available: https://t.co/00oWFTjiWX
We’re excited for #CARTCR! Stop by our booth (E88) and catch our Tech Slam on Sept. 21st @ 10:40am.
James Lim (CSO) will be speaking about workflows for immunosuppressive solid tumor modeling and CGT candidate selection. See you there!
#genetherapy#celltherapy#immunotherapy
"From Basic Research to Cell Therapy Development, a New Approach to Cell Culturing Offers More Reliable Results," by @XcellBio from the latest CLS Bulletin: Medtech Spotlight (page 25) https://t.co/DydVyr2WWq 👀
If you answered yes to these questions, congratulations! You are eligible for our Avatar Explorer Program. Click the link in our bio to find out more 👏
We are pleased to join the #cell and #gene#therapy community at the @Phacilitate#AdvancedTherapies week in Miami Beach. Our CEO @Brian_Feth will discuss successful fundraising strategies, informed in part from our own recently announced Series B. https://t.co/xDqEPu6IKx
Congrats to @XcellBio for raising $27.5 M Series B Financing. They were one of the original companies to complete CLS FAST advisory program. Now pioneering built-to purpose technology platforms for cell and gene-based therapies. #FosteringInnovation
READ: https://t.co/7PIOWWYqox
Excited to share news of our successful Series B led by Casdin Capital & new investors Dynamk Capital, Formic Ventures, and Labcorp. Great start to the new year as our amazing team works to improve the performance of #cell & #gene therapies!
https://t.co/YESklsy4T4
1/ @XcellBio: Brian Feth and James Lim share the story of how a conversation that started while standing in a line for pizza @BPEPUCB event @UCBerkeley @Cal resulted in launching the startup where they recently closed their Series B funding. Learn more https://t.co/qiHp8HLwfU